Explore all subjects

The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Physicians who Specialize in Alcohol Withdrawal

Analysis of: OREXIGEN(TM) Therapeutics Initiates its Third Phase III Trial for Contrave(TM) to Treat Obesity (biz.yahoo.com)
It is fundamentally a good idea to focus on central nervous system interventions for over-eating, as opposed to metabolic regulation of glucose catabolism in the periphery.  It is also very economical ("sound business") to use agents that are not patent-protected to try this really good idea. ...
Analysis of: Weight Loss Maintenance for Kids Benefits from Extended Intervention (www.medpagetoday.com)
Obesity treatment works in the short-term but likely needs to be extended over a life-time to be continuously effective.  This is the same as management of any chronic illness.  The surgical intervention model of a single procedure to "cure" complex biopsychosocial problems is naive and s...
Lawrence Ginsberg, MD, President
Red Oak Psychiatry Associates, P. A.
Analysis of: Vanda Pharmaceuticals Submits Iloperidone New Drug Application (www.pipelinereview.com)
1. Iloperidone has demonstrated efficacy in treating positive and negative symptoms of schizophrenia and also has a favorable safety profile. 2. Vanda has utilized pharmacogenetic studies to identify a group of schizophrenic patients that will benefit from this agent that binds to a number of serotonin...
Analysis of: Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels (www.pipelinereview.com)
I often marvel at the way different drugs weather the FDA storm and the varying vehemence of the press in terms of how they hold the respective pharmaceutical companies responsible for their products.  Chronic use of olanzapine causes significant metabolic changes which are likely to have adverse...
Lawrence Ginsberg, MD, President
Red Oak Psychiatry Associates, P. A.
Analysis of: DOV 21,947 Demonstrates Significant Body Weight and BMI Reductions in Drug Compliant Subjects in Phase Ib Clinical Study (www.medicalnewstoday.com)
1. DOV 21,947 in a phase Ib study produced a statistically significant reduction in plasma triglyceride levels, body weight, and Body Mass Index (BMI). 2. This compound is believed to not only manage depression but also impact weight gain. 3. A phase II study of DOV 21,947 is being delayed until the...
Analysis of: FDA Warns About Misuse Of Fentora Cancer Pain Drug (www.medicalnewstoday.com)
It is very important to understand that potent opioid agonists should only be used when a patient has had long-term opioid treatment.  Moreover, breakthrough pain has significant psychological overlay and using a cannon when a small pistol will do is potentially a reaction of the physician who...
Analysis of: Feel Pudgy? There’s a Shot for That (www.nytimes.com)
Beware of easy solutions for feeling pudgy, they may decrease fat deposits but will they change your self-image?  To add to the problem, regulation in this field is miniscule.  Will we have a repeat of breast implants, namely adding fat "in all the right places"?
Lawrence Ginsberg, MD, President
Red Oak Psychiatry Associates, P. A.
Analysis of: Shire withdraws some ADHD skin patches (www.reuters.com)
1. Shire has withdrawn patches that had defective patch liners. 2. This defect is not related to safety or efficacy issues. 3. The cost to Shire is less than $10 million.
Analysis of: Anesiva Initiates New Phase 2 Trial of Adlea(TM) for Pain Relief Following Knee Replacement Surgery (www.pipelinereview.com)
While opioids are arguably the best analgesics for acute and subacute pain there are significant systemic side effects such as mental status changes and nausea which do not make it ideal.  There are those who are addiction-prone or have previously had addiction who should avoid opioids or other...
Analysis of: Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review (www.medicalnewstoday.com)
BLOOM (Behavioral modification and Lorcaserin for Overweight and Obesity Management) is interesting in that it recognizes the need to test any pharmaceutical approaches to obesity within the background of behavioral interventions.  This is for a number of reasons, most important among these is...

Previous Page : 1 2 3 4 5 6 7 8 9 10 11 12 Next21 to 30 of 132

Analytics


Generated at 2009-01-07T19:00:58.307